NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
7.97
+0.41 (5.42%)
At close: Nov 16, 2026, 4:00 PM EST
7.82
-0.15 (-1.88%)
After-hours: Nov 16, 2026, 7:39 PM EST

NeuroPace Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
106.7599.9979.9165.4245.5245.18
Revenue Growth
29.17%25.13%22.14%43.72%0.75%9.83%
Cost of Revenue
23.6522.7720.8217.313.0311.75
Gross Profit
83.0977.2259.0948.1232.4933.44
Selling, General & Admin
66.0165.6757.154.5251.3438.96
Research & Development
27.2827.8923.6520.7821.9518.21
Operating Expenses
93.2993.5680.7675.373.2957.17
Operating Income
-10.19-16.34-21.67-27.17-40.79-23.74
Interest Expense
-6.23-7.46-8.8-8.52-7.53-7.41
Interest & Investment Income
2.242.823.023.051.580.45
Other Non Operating Income (Expenses)
-0.03-0.030.08-0.02-5.38
EBT Excluding Unusual Items
-14.21-21.01-27.37-32.64-46.73-36.08
Gain (Loss) on Sale of Investments
-0.370.040.23-0.32-0.36-
Other Unusual Items
0.03-0.5----
Pretax Income
-14.55-21.47-27.14-32.96-47.08-36.08
Net Income
-18.92-21.47-27.14-32.96-47.08-36.08
Net Income to Common
-18.92-21.47-27.14-32.96-47.08-36.08
Net Income Growth
------
Shares Outstanding (Basic)
343329262517
Shares Outstanding (Diluted)
343329262517
Shares Change
6.40%12.35%12.67%5.11%48.08%8038.86%
EPS (Basic)
-0.56-0.66-0.93-1.27-1.91-2.17
EPS (Diluted)
-0.56-0.66-0.93-1.27-1.91-2.17
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-12.42-11.34-18.26-19.87-37.47-24.96
Free Cash Flow Per Share
-0.37-0.35-0.63-0.77-1.52-1.50
Gross Margin
77.84%77.23%73.94%73.56%71.38%74.00%
Operating Margin
-9.55%-16.34%-27.12%-41.54%-89.62%-52.53%
Profit Margin
-17.72%-21.47%-33.97%-50.38%-103.43%-79.85%
Free Cash Flow Margin
-11.63%-11.34%-22.85%-30.38%-82.32%-55.24%
EBITDA
-9.91-16.1-21.46-27-40.53-23.44
EBITDA Margin
-9.28%-16.10%-26.86%-41.27%-89.03%-51.88%
D&A For EBITDA
0.290.240.210.170.270.3
EBIT
-10.19-16.34-21.67-27.17-40.79-23.74
EBIT Margin
-9.55%-16.34%-27.12%-41.54%-89.62%-52.53%
Advertising Expenses
-0.50.70.70.70.1
SEC Filings: 10-K · 10-Q